Literature DB >> 12819820

Alpha(v)beta(3) integrin in angiogenesis and restenosis.

J S Kerr1, S A Mousa, A M Slee.   

Abstract

Various integrins are thought to be intimately involved in several pathological processes, including cancers (solid tumors and metastasis), cardiovascular diseases (stroke and heart failure), inflammatory diseases (rheumatoid arthritis) and ocular pathologies. The mechanism of the involvement of integrins in these acute and chronic disease states is slowly being elucidated. Recently, various therapeutic candidates, including antibodies, cyclic peptides and peptidomimetics, have been clinically evaluated and have been shown to successfully modulate certain disease processes. This review focuses on the key role of the alpha(v) integrin (alpha(v)beta(3)) in the angiogenic processes in diseases such as cancer, restenosis following percutaneous transluminal coronary angioplasty, stroke, ocular disease and rheumatoid arthritis. (c) 2001 Prous Science. All rights reserved.

Entities:  

Year:  2001        PMID: 12819820

Source DB:  PubMed          Journal:  Drug News Perspect        ISSN: 0214-0934


  6 in total

Review 1.  Molecular imaging by MRI.

Authors:  Patrick M Winter; Shelton D Caruthers; Samuel A Wickline; Gregory M Lanza
Journal:  Curr Cardiol Rep       Date:  2006-02       Impact factor: 2.931

2.  Role of RGD-containing ligands in targeting cellular integrins: Applications for ovarian cancer virotherapy (Review).

Authors:  Lena J Gamble; Anton V Borovjagin; Qiana L Matthews
Journal:  Exp Ther Med       Date:  2010-03       Impact factor: 2.447

3.  Delivery of Polymeric Nanoparticles to Target Vascular Diseases.

Authors:  Edward Agyare; Karunyna Kandimalla
Journal:  J Biomol Res Ther       Date:  2014-01

4.  Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance.

Authors:  Cecilia S Leung; Tsz-Lun Yeung; Kay-Pong Yip; Kwong-Kwok Wong; Samuel Y Ho; Lingegowda S Mangala; Anil K Sood; Gabriel Lopez-Berestein; Jianting Sheng; Stephen Tc Wong; Michael J Birrer; Samuel C Mok
Journal:  J Clin Invest       Date:  2017-12-18       Impact factor: 14.808

5.  MR molecular imaging of angiogenesis using targeted perfluorocarbon nanoparticles.

Authors:  S D Caruthers; P M Winter; S A Wickline; G M Lanza; J Keupp
Journal:  Medicamundi       Date:  2010

6.  Evolutionarily conserved sequence motif analysis guides development of chemically defined hydrogels for therapeutic vascularization.

Authors:  Jia Jia; Eun Je Jeon; Mei Li; Dylan J Richards; Soojin Lee; Youngmee Jung; Ryan W Barrs; Robert Coyle; Xiaoyang Li; James C Chou; Michael J Yost; Sharon Gerecht; Seung-Woo Cho; Ying Mei
Journal:  Sci Adv       Date:  2020-07-08       Impact factor: 14.136

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.